Alcon AG | ALC - Operating Profit

Stock Price
67.06
Daily Change
2.80 4.36%
Monthly
7.02%
Yearly
-20.66%
Q1 Forecast
62.72

Alcon AG reported $332M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Bayer EUR -543M 556M Sep/2025
Essilor EUR 1.38B 626M Dec/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.21B 180M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
Sonova Holding CHF 296.8M 156.9M Dec/2025
UCB EUR 1B 678M Dec/2024